Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice
Keywords: نیتروپروساید سدیم; Atherosclerosis; Inflammation; Endothelial function; P2Y12; Ticagrelor; Ach; acetylcholine; ACS; acute coronary syndrome; ADP; adenosine diphosphate; apoEâ/â; apolipoprotein E-deficient; Ctrl; control; HUVEC; human umbilical vein endothelial cell; ICA